COPHF: AI 评分 56/100 — AI 分析 (4月 2026)

Creso Pharma Limited develops and commercializes pharmaceutical-grade cannabis and hemp-based nutraceutical products. The company targets human and animal health across Europe, the Middle East, North America, and the Asia Pacific regions.

Key Facts: AI Score: 56/100 Sector: Healthcare

公司概况

概要：

Creso Pharma Limited focuses on developing and commercializing cannabis and hemp-based products for both human and animal health, operating in a global market with a diverse product portfolio including nutraceuticals and therapeutic treatments, but faces challenges related to profitability and market competition.

COPHF是做什么的？

Creso Pharma Limited, established in 2015 and headquartered in Nedlands, Australia, is a healthcare company specializing in the development, registration, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products. The company's mission is to provide innovative and effective treatments for both human and animal health. Creso Pharma operates across several key regions, including Europe, the Middle East, North America, and the Asia Pacific, reflecting its global ambitions and market reach. The company's product portfolio includes a range of therapeutic and nutraceutical products. Key offerings include anibidiol, a complementary feed product designed for companion animals to support their well-being. CannaQIX is another prominent product, a nutraceutical containing hemp oil extract, vitamins, and zinc, aimed at reducing stress and supporting psychological and nervous functions. Additionally, Creso Pharma develops and markets topical and skin care products, such as cannaDOL, a CBD-based topical gel formulated with cooling and warming essential oils. Creso Pharma's business activities encompass the entire value chain, from cultivation and processing of cannabis to the manufacturing and distribution of finished products. The company cultivates, processes, and sells cannabis products, as well as supplies cannabis retail products, ensuring a consistent supply and quality control. Creso Pharma aims to establish itself as a leader in the cannabis and hemp-based health and wellness sector through continuous innovation, strategic partnerships, and expansion into new markets.

COPHF的投资论点是什么？

Creso Pharma Limited presents a speculative investment opportunity within the rapidly evolving cannabis and hemp-based health and wellness market. The company's diverse product portfolio targeting both human and animal health provides multiple revenue streams. However, the company's negative profit margin of -377.3% raises concerns about its financial sustainability. Investors should closely monitor Creso Pharma's ability to improve its profitability and achieve sustainable growth. Key catalysts include successful product launches and expansion into new geographic markets. The high beta of -24.81 indicates extreme volatility compared to the market, suggesting a high-risk investment profile. The company's ability to navigate regulatory hurdles and maintain a competitive edge will be crucial for its long-term success.

COPHF在哪个行业运营？

Creso Pharma Limited operates within the rapidly expanding cannabis and hemp-based health and wellness industry. This sector is characterized by increasing consumer acceptance, evolving regulatory landscapes, and growing demand for alternative health solutions. The market is highly competitive, with numerous companies vying for market share. Creso Pharma's focus on pharmaceutical-grade products and its presence in multiple geographic regions position it to capitalize on the industry's growth. However, the company faces competition from established pharmaceutical companies and other cannabis producers. The global cannabis market is projected to reach billions of dollars in the coming years, presenting significant opportunities for companies like Creso Pharma.

Drug Manufacturers - Specialty & Generic

Healthcare

COPHF有哪些增长机遇？

Expansion into New Geographic Markets: Creso Pharma can drive growth by expanding its presence in key markets such as North America and Europe. The increasing legalization of cannabis and hemp-based products in these regions presents significant opportunities for market penetration. Strategic partnerships with local distributors and retailers can facilitate market entry and accelerate revenue growth. The global cannabis market is projected to reach $47 billion by 2027, providing a substantial addressable market for Creso Pharma.
Development of Innovative Products: Investing in research and development to create innovative cannabis and hemp-based products can drive growth and differentiate Creso Pharma from its competitors. Focusing on specific therapeutic areas, such as pain management and mental health, can attract a loyal customer base and generate recurring revenue. The nutraceutical market is expected to grow to $400 billion by 2030, offering a significant opportunity for Creso Pharma to expand its product portfolio.
Strategic Acquisitions and Partnerships: Pursuing strategic acquisitions and partnerships with other companies in the cannabis and hemp industry can accelerate growth and expand Creso Pharma's market reach. Acquiring companies with complementary product portfolios or established distribution networks can create synergies and enhance the company's competitive position. The cannabis industry is consolidating, with larger companies acquiring smaller players to gain market share and expand their operations.
Focus on Animal Health Products: The animal health market presents a significant growth opportunity for Creso Pharma, particularly with its anibidiol product. As pet owners increasingly seek natural and alternative treatments for their animals, the demand for cannabis and hemp-based products for pets is expected to grow. Expanding the anibidiol product line and developing new animal health products can drive revenue growth and establish Creso Pharma as a leader in this niche market. The global animal health market is projected to reach $70 billion by 2027.
Enhancing E-commerce Capabilities: Investing in e-commerce capabilities and online marketing can drive direct-to-consumer sales and expand Creso Pharma's customer base. Developing a user-friendly online platform and implementing targeted marketing campaigns can attract new customers and increase brand awareness. The e-commerce market is growing rapidly, with consumers increasingly purchasing health and wellness products online. Strengthening its online presence can enable Creso Pharma to reach a wider audience and generate higher sales.

Market capitalization of $0.13 billion indicates a small-cap company with potential for growth but also higher risk.
Negative P/E ratio of -0.40 reflects the company's current lack of profitability.
Profit margin of -377.3% highlights significant challenges in achieving profitability.
Gross margin of 3.3% suggests limited ability to generate profit from sales after accounting for the cost of goods sold.
Beta of -24.81 indicates extreme volatility compared to the market.

COPHF提供哪些产品和服务？

Develops pharmaceutical-grade cannabis products.
Registers and commercializes cannabis and hemp-based nutraceuticals.
Creates treatments for human health using cannabis and hemp.
Develops treatments for animal health using cannabis and hemp.
Cultivates and processes cannabis products.
Supplies cannabis retail products.
Markets topical and skin care products containing CBD.

COPHF如何赚钱？

Develops and sells cannabis and hemp-based products for human and animal health.
Generates revenue through the sale of nutraceuticals and therapeutic products.
Cultivates and processes cannabis to ensure product quality and supply.
Distributes products through retail channels and online platforms.

Individuals seeking alternative health and wellness solutions.
Pet owners looking for natural treatments for their animals.
Retailers and distributors of health and wellness products.
Pharmacies and healthcare providers.

Proprietary formulations and intellectual property related to cannabis and hemp-based products.
Established presence in multiple geographic regions, including Europe, the Middle East, North America, and Asia Pacific.
Focus on pharmaceutical-grade products, ensuring high quality and safety standards.
Diverse product portfolio targeting both human and animal health.

什么因素可能推动COPHF股价上涨？

Upcoming: Potential regulatory approvals for new cannabis and hemp-based products in key markets.
Ongoing: Expansion of distribution network through strategic partnerships.
Ongoing: Increasing consumer acceptance of cannabis and hemp-based health and wellness products.
Upcoming: Launch of new innovative products targeting specific therapeutic areas.
Ongoing: Growing demand for animal health products containing cannabis and hemp.

COPHF的主要风险是什么？

Potential: Changes in regulatory landscape and stricter regulations on cannabis and hemp products.
Ongoing: Intense competition from established pharmaceutical companies and other cannabis producers.
Potential: Fluctuations in cannabis and hemp prices affecting profitability.
Potential: Negative public perception of cannabis products impacting demand.
Ongoing: Limited financial resources and potential need for additional funding.

COPHF的核心优势是什么？

Diverse product portfolio targeting both human and animal health.
Presence in multiple geographic regions.
Focus on pharmaceutical-grade cannabis and hemp-based products.
Established cultivation and processing capabilities.

COPHF的劣势是什么？

Negative profit margin and limited profitability.
High beta indicating significant market volatility.
Reliance on evolving regulatory landscape.
Limited brand recognition compared to larger competitors.

COPHF有哪些机遇？

Expansion into new geographic markets.
Development of innovative cannabis and hemp-based products.
Strategic acquisitions and partnerships.
Growth in the animal health market.

COPHF面临哪些威胁？

Intense competition from established pharmaceutical companies and other cannabis producers.
Changing regulatory landscape and potential for stricter regulations.
Fluctuations in cannabis and hemp prices.
Potential for negative public perception of cannabis products.

COPHF的竞争对手是谁？

Advanced Agrilytics, Inc. — Focuses on agricultural technology in the cannabis sector. — (AAPGV)
American Green, Inc. — Operates in the cannabis and CBD markets. — (AMEUF)
Amg Medical Inc. — Develops and distributes medical cannabis products. — (AMGXF)
CMC Metals Ltd. — Primarily focused on metal exploration, but may have tangential interests in cannabis-related materials. — (CMXC)
Canivate Growing Systems Corp. — Provides technology and infrastructure for cannabis cultivation. — (CNVCF)

Key Metrics

MoonshotScore: 56/100

Company Profile

CEO: William Lay
Headquarters: Nedlands, AU
Founded: 2017

AI Insight

AI analysis pending for COPHF

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Creso Pharma Limited do?

Creso Pharma Limited is a healthcare company that develops, registers, and commercializes pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. They operate in Europe, the Middle East, North America, and the Asia Pacific. Their product range includes anibidiol for animals, cannaQIX for stress reduction in humans, and cannaDOL for topical skin care, positioning them as a diversified player in the cannabis-based health and wellness market.

What do analysts say about COPHF stock?

Analyst sentiment on COPHF is currently not available due to limited coverage. Key valuation metrics such as P/E ratio (-0.40) and profit margin (-377.3%) indicate financial challenges. Growth considerations revolve around successful product launches, market expansion, and regulatory approvals. Investors should conduct thorough due diligence and assess the company's ability to improve profitability and achieve sustainable growth before making any investment decisions.

What are the main risks for COPHF?

Creso Pharma Limited faces several risks, including intense competition in the cannabis and hemp-based health and wellness market. The evolving regulatory landscape presents uncertainty, with potential for stricter regulations impacting the company's operations. Financial risks include negative profit margins and the need for additional funding. Fluctuations in cannabis and hemp prices can also affect profitability. Investors should carefully consider these risks before investing in COPHF.